US FDA Open To Innovative Statistical Approaches For Rare Disease

 
• By Sarah Karlin-Smith

Move over big data, a biostatistician calls for more people to think small for rare diseases and FDA officials indicate openness to the trial approaches laid out.

woodenblocks that say "think" and a block that has big on one face and small on the other face
While big data is all the rage, more statisticians need to be working on being efficient with small data, FDA-Duke meeting speaker says • Source: Shutterstock

More from Rare Diseases

More from Conferences